WallStSmart
CELZ

Creative Medical Technology Holdings Inc

NASDAQ: CELZ · HEALTHCARE · BIOTECHNOLOGY

$2.25
+1.35% today

Updated 2026-04-30

Market cap
$8.50M
P/E ratio
P/S ratio
1,417.06x
EPS (TTM)
$-2.52
Dividend yield
52W range
$2 – $6
Volume
0.1M

Creative Medical Technology Holdings Inc (CELZ) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$1139.00$-12857.00$-57164.00$-30742.00$-13661.00$-13959.00$-16774.00$-22907.00$-17320.00$-14638.00$-445232.00$-889621.00$-1.05M$-1.21M$-434556.00$-2.22M$-7.80M$-8.03M$-5.30M$-5.86M
Capital expenditures$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$10000.00$0.00$0.00$3.00$250000.00$0.00$4.00$100000.00$200000.00$5.00
Depreciation
Stock-based comp$2565.00$144160.00$1877.00$0.00$170323.00$595380.00$68746.00$36648.00$36648.00$3485.00
Free cash flow$1139.00$-12857.00$-57164.00$-30742.00$-13661.00$-13959.00$-16774.00$-22907.00$-17320.00$-14638.00$-455232.00$-889621.00$-1.05M$-1.21M$-684556.00$-2.22M$-7.80M$-8.13M$-5.50M$-5.86M
Investing cash flow
Financing cash flow
Dividends paid$4.78M
Share repurchases
Debt repayment
Net change in cash